Harmon Seth bought VRDN
March 3, 2026 · Form 4 insider transaction
Harmon Seth bought 6,267 shares of Viridian Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,267
Price
N/A
Total value
N/A
InsiderHarmon Seth
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 3, 2026
Filing dateMarch 4, 2026
Shares owned after9,881
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of the Issuer.; Includes 903 shares acquired on March 17, 2025 under Viridian Therapeutics, Inc.'s 2016 Employee Stock Purchase Plan and 1,000 shares acquired on September 17, 2025 under Viridian Therapeutics, Inc.'s 2025 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).